How to optimize In vivo preclinical efficacy evaluation of synergistic immuno-oncology drug candidates

Yan WANG, PhD, MD, R&D department, Project Manager – Immuno-oncology specialist, INOVOTION, will give a talk during a webinar, June 15th

During the webinar Dr Yan Wang will discuss:

• Benefits of setting up an early in vivo efficacy evaluation to optimize probability of success for synergestic Immuno-oncology drug candidate
• Learn about chicken embryo model
• Understand the interest of xenograft on chicken embryo model
• Chicken embryo in vivo model for early efficacy and toxicity evaluation of Immuno-oncology drug candidates
• Understand pros and cons of chicken embryo model vs mouse model in Immuno-oncology
• Case studies

Learning Objectives

• Benefits of setting up an early in vivo efficacy evaluation to optimize probability of success for synergestic Immuno-oncology drug candidate
• Chicken embryo in vivo model for early efficacy and toxicity evaluation of Immuno-oncology drug candidates
• Understand pros and cons of chicken embryo model vs mouse model in immuno-oncology

Click here to learn more and register for free. http://www.healthtech.com/inovotion-a-fast-and-affordable-method/